These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 31312205)
1. Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages. Lu L; Arranz-Trullén J; Prats-Ejarque G; Pulido D; Bhakta S; Boix E Front Immunol; 2019; 10():1500. PubMed ID: 31312205 [TBL] [Abstract][Full Text] [Related]
2. Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model. Lu L; Wei R; Prats-Ejarque G; Goetz M; Wang G; Torrent M; Boix E Cell Mol Life Sci; 2021 Mar; 78(6):2963-2985. PubMed ID: 33226440 [TBL] [Abstract][Full Text] [Related]
3. Two human host defense ribonucleases against mycobacteria, the eosinophil cationic protein (RNase 3) and RNase 7. Pulido D; Torrent M; Andreu D; Nogués MV; Boix E Antimicrob Agents Chemother; 2013 Aug; 57(8):3797-805. PubMed ID: 23716047 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106a Inhibits Autophagy Process and Antimicrobial Responses by Targeting ULK1, ATG7, and ATG16L1 During Mycobacterial Infection. Liu K; Hong D; Zhang F; Li X; He M; Han X; Zhang G; Xu G; Stonehouse NJ; Jiang Z; An W; Guo L Front Immunol; 2020; 11():610021. PubMed ID: 33505399 [TBL] [Abstract][Full Text] [Related]
5. Soybean lectin induces autophagy through P2RX7 dependent activation of NF-κB-ROS pathway to kill intracellular mycobacteria. Mishra A; Behura A; Kumar A; Ghosh A; Naik L; Mawatwal S; Mohanty SS; Mishra A; Saha S; Bhutia SK; Singh R; Dhiman R Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129806. PubMed ID: 33253803 [TBL] [Abstract][Full Text] [Related]
6. Host-directed therapy with amiodarone in preclinical models restricts mycobacterial infection and enhances autophagy. Kilinç G; Boland R; Heemskerk MT; Spaink HP; Haks MC; van der Vaart M; Ottenhoff THM; Meijer AH; Saris A Microbiol Spectr; 2024 Aug; 12(8):e0016724. PubMed ID: 38916320 [TBL] [Abstract][Full Text] [Related]
7. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy. Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154 [TBL] [Abstract][Full Text] [Related]
8. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy. Wang J; Sha J; Strong E; Chopra AK; Lee S Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262 [TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids Suppress Antimicrobial Autophagy and Nitric Oxide Production and Facilitate Mycobacterial Survival in Macrophages. Wang J; Wang R; Wang H; Yang X; Yang J; Xiong W; Wen Q; Ma L Sci Rep; 2017 Apr; 7(1):982. PubMed ID: 28428627 [TBL] [Abstract][Full Text] [Related]
10. Bfl-1/A1 acts as a negative regulator of autophagy in mycobacteria infected macrophages. Kathania M; Raje CI; Raje M; Dutta RK; Majumdar S Int J Biochem Cell Biol; 2011 Apr; 43(4):573-85. PubMed ID: 21167304 [TBL] [Abstract][Full Text] [Related]
12. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
13. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019 [TBL] [Abstract][Full Text] [Related]
14. An integrated surrogate model for screening of drugs against Mycobacterium tuberculosis. Gupta A; Bhakta S J Antimicrob Chemother; 2012 Jun; 67(6):1380-91. PubMed ID: 22398649 [TBL] [Abstract][Full Text] [Related]
15. Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation. Parihar SP; Guler R; Khutlang R; Lang DM; Hurdayal R; Mhlanga MM; Suzuki H; Marais AD; Brombacher F J Infect Dis; 2014 Mar; 209(5):754-63. PubMed ID: 24133190 [TBL] [Abstract][Full Text] [Related]
16. Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation. Pulido D; Arranz-Trullén J; Prats-Ejarque G; Velázquez D; Torrent M; Moussaoui M; Boix E Int J Mol Sci; 2016 Apr; 17(4):552. PubMed ID: 27089320 [TBL] [Abstract][Full Text] [Related]
17. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2. Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573 [TBL] [Abstract][Full Text] [Related]
18. Sclerotiorin inhibits protein kinase G from Mycobacterium tuberculosis and impairs mycobacterial growth in macrophages. Chen D; Ma S; He L; Yuan P; She Z; Lu Y Tuberculosis (Edinb); 2017 Mar; 103():37-43. PubMed ID: 28237032 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages. Dharra R; Radhakrishnan VS; Prasad T; Thakur Z; Cirillo JD; Sheoran A; Pandey AK; Kulharia M; Mehta PK Sci Rep; 2019 Jul; 9(1):10084. PubMed ID: 31300732 [TBL] [Abstract][Full Text] [Related]
20. Exploring the mechanisms of action of human secretory RNase 3 and RNase 7 against Candida albicans. Salazar VA; Arranz-Trullén J; Navarro S; Blanco JA; Sánchez D; Moussaoui M; Boix E Microbiologyopen; 2016 Oct; 5(5):830-845. PubMed ID: 27277554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]